Data / Form D filings / MediSix Therapeutics, Inc.
MediSix Therapeutics, Inc.: Form D filings
MediSix Therapeutics, Inc., a biotechnology company in Boston, MA, filed 3 Form D notices with the SEC between 2019 and 2023. The latest, on August 4, 2023, reports $22.5 million sold of a $22.5 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 500 BOYLSTON STREET, SUITE 1380, Boston, MA, 02116
- Phone
- (617) 933-3770
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1790058
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 4, 2023 | Amendment | $22,500,000 | $22,500,000 | 5 | Apr 1, 2021 | sec.gov | |
| Apr 13, 2021 | New notice | $22,000,000 | $15,000,000 | $7,000,000 | 4 | Apr 1, 2021 | sec.gov |
| Oct 2, 2019 | New notice | $20,358,686 | $20,358,686 | 4 | Sep 17, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew R. Bruce | Executive Officer, Director | |
| William A. Harrington | Director | |
| Michael Carusi | Director | |
| George A. Poste | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 31, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MediSix Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.